Cadrenal

CVKD

CVKD Cadrenal NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    CVKD Chart
    See on advanced chart >

    About

    Cadrenal Therapeutics, Inc. was incorporated as a Delaware corporation on January 25, 2022. They are focused on developing tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism (blood clots) of...
    • Highlight
      A biopharmaceutical company for the prevention of cardiogenic systemic thromboembolism in patients with end-stage renal disease and atrial fibrillation
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      01/20/2023
    • Established Date
      01/25/2022
    • Full-time Employees
      4
    • Address
      822 A1A North Suite 320 Ponte Vedra Florida 32082
    • Tel
      1-904-3000701
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-12 23:19:11